PCI Pharma extends global clinical supply-chain services in Europe

By Akshay Kedari  | Date: 2020-07-30

PCI Pharma extends global clinical supply-chain services in Europe

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) in Berlin.

According to credible sources, the new COE facility is PCI Pharma’s efforts to extend its clinical supply-chain network in Europe, which would complement the existing services it provides in Ireland and UK.

The Berlin-based COE will cover a space of 17,000 square feet which will primarily focus on packaging, storing and distribution of pharmaceutical and biopharmaceutical therapies in Europe, sources claimed.

The facility is reportedly ideal to provide services to clinical trials eco-system in the region. It presently has around 38,100 active trial centers across Europe, of which France ranks first with 7,370 active trials followed by Germany, with around 4,418 trial centers.

VP and GM of Global Clinical Operations & Supply at PCI Pharma Services, Brian Keesee reportedly said that this expansion will enable the company to cater to the needs of European as well as global clients through the COE facility in Berlin. He further claimed that Berlin is an exceptional logistics center and will ensure minimum disruptions in the supply-chain amid Brexit.

Salim Haffar, CEO at PCI Pharma Services, also stated that the company’s strategy has always focused on increasing the capacity as well as the capabilities of its network of clinical trial services. He added that the recent acquisition of Bellwyck Pharma Services will enable PCI Pharma to improve its capabilities through the Berlin facility, in a bid to support the flourishing clinical trial sector in Europe.

Salim also confirmed that the recent investment will facilitate the company to offer clinical trial solutions of their advanced medicines to clients across the globe.

For those uninitiated, PCI Pharma is a major contributor to global healthcare industry since it offers drug development solutions that help in enhancing numerous medical products.

Source credits: https://www.businesswire.com/news/home/20200728005211/en/PCI-Pharma-Services-Announces-Global-Expansion-Clinical

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More >>

More News By Akshay Kedari

Google Fi confirms data breach, leaking millions of customer’s data

Google Fi confirms data breach, leaking millions of customer’s data

By Akshay Kedari

Google Fi, Google's cell network operator, has reportedly revealed a data breach, which is most likely related to the T-recent Mobile's security disaster, which allowed hackers to leak millions of customers' personal information. The p...

European semiconductor giant ASML forecasts a sales surge for 2023

European semiconductor giant ASML forecasts a sales surge for 2023

By Akshay Kedari

Dutch semiconductor company ASML has reportedly forecast a revenue jump for the year 2023 as the global semiconductor industry anticipates a reacceleration of growth during the second half of this year. According to the firm, its net sales  f...

Interfor Corporation acquires 100% equity interest in Chaleur Forest Products

Interfor Corporation acquires 100% equity interest in Chaleur Forest Products

By Akshay Kedari

Following this funding, Interfor's long-term debt will hold a weighted average interest of 5.30% Interfor registered a Net Debt to the Invested Capital ratio of nearly 10% as of October 31, 2022 Interfor Corporation, one of the world...

ESR's ARA and Export-Import Bank of China partner in a deal worth US$1B

ESR's ARA and Export-Import Bank of China partner in a deal worth US$1B

By Akshay Kedari

Leading real estate services and investment company, ESR Group Limited, has recently announced that its exclusively-owned subsidiary, ARA and the Export-Import Bank of China have inked a breakthrough collaboration in a deal worth USD 1 billion infras...

Circularise nabs $11M to bring circular economy to industrial supply chains

Circularise nabs $11M to bring circular economy to industrial supply chains

By Akshay Kedari

Leading software platform, Circularise recently announced that it has raised $11.3 million (€11 million) in funding as part of its Series A round in a bid to advance its mission to bring a circular economy to industrial supply chains. The fun...